Stockholders' Equity - Schedule of Changes in Stockholders' Deficit by Component, Net of Tax (Details) - USD ($) $ / shares in Units, shares in Thousands |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Oct. 31, 2022 |
Jul. 31, 2022 |
Apr. 30, 2022 |
Oct. 31, 2021 |
Jul. 31, 2021 |
Apr. 30, 2021 |
Oct. 31, 2022 |
Oct. 31, 2021 |
Nov. 30, 2022 |
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Beginning balance | $ 740,000,000 | $ 681,000,000 | $ 849,000,000 | $ 1,328,000,000 | $ 1,128,000,000 | $ 965,000,000 | $ 849,000,000 | $ 965,000,000 | |
Common shares issued under stock plans | 18,000,000 | (17,000,000) | (10,000,000) | (51,000,000) | (6,000,000) | 9,000,000 | |||
Stock-based compensation expense | 165,000,000 | 163,000,000 | 146,000,000 | 140,000,000 | 148,000,000 | 114,000,000 | |||
Shares issued related to business combination | 10,000,000 | 3,000,000 | |||||||
Settlement of liability-classified restricted common shares | 3,000,000 | 5,000,000 | 3,000,000 | 8,000,000 | 3,000,000 | ||||
Net income | 198,000,000 | 186,000,000 | 146,000,000 | 137,000,000 | 115,000,000 | 156,000,000 | 530,000,000 | 408,000,000 | |
Other comprehensive income (loss) | (38,000,000) | (21,000,000) | (24,000,000) | 11,000,000 | (11,000,000) | 24,000,000 | |||
Repurchase and retirement of common shares | (180,000,000) | (257,000,000) | (436,000,000) | (288,000,000) | (46,000,000) | (143,000,000) | |||
Ending balance | $ 906,000,000 | $ 740,000,000 | $ 681,000,000 | $ 1,280,000,000 | $ 1,328,000,000 | $ 1,128,000,000 | $ 906,000,000 | $ 1,280,000,000 | |
Subsequent Event | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Stock repurchase authorized amount | $ 5,000,000,000 | ||||||||
Common Stock Repurchase Program | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Common stock repurchased and retired (in shares) | 893 | 980 | 4,368 | 1,659 | |||||
Repurchased shares of its common stock on the open market, average repurchase price per share (in usd per share) | $ 201.33 | $ 292.91 | $ 199.83 | $ 286.95 | |||||
Common stock shares remained available for repurchase under repurchase plans (in shares) | 4,000 | 10,000 | 4,000 | 10,000 | |||||
Common stock and additional paid-in capital | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Beginning balance (in shares) | 216,000 | 217,000 | 218,000 | 220,000 | 220,000 | 220,000 | 218,000 | 220,000 | |
Beginning balance | $ 3,089,000,000 | $ 2,972,000,000 | $ 2,923,000,000 | $ 2,780,000,000 | $ 2,639,000,000 | $ 2,579,000,000 | $ 2,923,000,000 | $ 2,579,000,000 | |
Common shares issued under stock plans (in shares) | 1,000 | 1,000 | 1,000 | 1,000 | |||||
Common shares issued under stock plans | $ 18,000,000 | (17,000,000) | $ (10,000,000) | $ (51,000,000) | (6,000,000) | $ 9,000,000 | |||
Stock-based compensation expense | 165,000,000 | 163,000,000 | 146,000,000 | 140,000,000 | $ 148,000,000 | 114,000,000 | |||
Shares issued related to business combination | $ 10,000,000 | $ 3,000,000 | |||||||
Settlement of liability-classified restricted common shares | $ 3,000,000 | $ 5,000,000 | $ 3,000,000 | ||||||
Repurchase and retirement of common shares (in shares) | (1,000) | (1,000) | (2,000) | (1,000) | (1,000) | ||||
Repurchase and retirement of common shares | $ (62,000,000) | $ (34,000,000) | $ (97,000,000) | $ (51,000,000) | $ (1,000,000) | $ (66,000,000) | |||
Ending balance (in shares) | 216,000 | 216,000 | 217,000 | 220,000 | 220,000 | 220,000 | 216,000 | 220,000 | |
Ending balance | $ 3,213,000,000 | $ 3,089,000,000 | $ 2,972,000,000 | $ 2,821,000,000 | $ 2,780,000,000 | $ 2,639,000,000 | $ 3,213,000,000 | $ 2,821,000,000 | |
Accumulated other comprehensive loss | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Beginning balance | (169,000,000) | (148,000,000) | (124,000,000) | (113,000,000) | (102,000,000) | (126,000,000) | (124,000,000) | (126,000,000) | |
Other comprehensive income (loss) | (38,000,000) | (21,000,000) | (24,000,000) | 11,000,000 | (11,000,000) | 24,000,000 | |||
Ending balance | (207,000,000) | (169,000,000) | (148,000,000) | (102,000,000) | (113,000,000) | (102,000,000) | (207,000,000) | (102,000,000) | |
Accumulated deficit | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Beginning balance | (2,180,000,000) | (2,143,000,000) | (1,950,000,000) | (1,339,000,000) | (1,409,000,000) | (1,488,000,000) | (1,950,000,000) | (1,488,000,000) | |
Net income | 198,000,000 | 186,000,000 | 146,000,000 | 137,000,000 | 115,000,000 | 156,000,000 | |||
Repurchase and retirement of common shares | (118,000,000) | (223,000,000) | (339,000,000) | (237,000,000) | (45,000,000) | (77,000,000) | |||
Ending balance | $ (2,100,000,000) | $ (2,180,000,000) | $ (2,143,000,000) | $ (1,439,000,000) | $ (1,339,000,000) | $ (1,409,000,000) | $ (2,100,000,000) | $ (1,439,000,000) |